10-Q quarterly report · filed Nov 10, 2026

CARLSMED, INC. (CARL) Q3 2026 10-Q Quarterly Report

Short answer

CARLSMED, INC. (CARL) filed its Q3 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $22M (up 64.9% year over year) with net income of −$12M.

Q3 2026 key financials · XBRL

Revenue
$22M
+64.9% YoY · +13.8% QoQ
Net income
−$12M
−43.6% YoY · −16.5% QoQ
Operating margin
-58.9%
Gross margin
77.3%
EPS (diluted)
−$0.45
−157.0% YoY · −15.4% QoQ

Source: XBRL data from the CARLSMED, INC. (CARL) Q3 2026 10-Q on SEC EDGAR. USD.

CARLSMED, INC. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $21.6M, up 64.9% YoY from $13.1M, driven by higher lumbar and cervical procedure volume
  • Gross margin 77.3% vs 75.9% YoY, aided by lower contract-manufacturer fees and digital production efficiencies
  • Worst profitability metric: operating margin negative 58.9% vs negative 69.1% YoY, with net loss $12.2M vs $8.5M
  • Cash, restricted cash, investments and securities $80.3M, with $15.6M debt outstanding at quarter-end
  • Nine-month operating cash outflow $29.0M, investing outflow $21.7M, primarily marketable-security purchases of $23.6M

Risk Factors

  • No material changes to previously disclosed Annual Report risk factors
  • Business operations vulnerable to unidentified risks and uncertainties
  • Financial condition and cash flows could be negatively affected by realized risks
  • Investment value exposed to adverse business, operational, and financial outcomes

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other CARLSMED, INC. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.